# New Animal Drugs For Use In Animal Feeds; Monensin and Bacitracin Methylene Disalicylate
> **Food and Drug Administration** · Final rule. · Published 1998-10-02 · Effective 1998-10-02 · 63 FR 52969
## Document
- **Document number:** 98-26425
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 63 FR 52969
- **CFR reference:** 21 CFR 558
- **Publication date:** 1998-10-02
- **Effective date:** 1998-10-02
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, A Division of Eli Lilly & Co. The supplemental NADA provides for using approved single ingredient monensin and bacitracin methylene disalicylate (BMD) Type A medicated articles to make an additional approved combination for a monensin/BMD Type C medicated turkey feed.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1998/10/02/98-26425/new-animal-drugs-for-use-in-animal-feeds-monensin-and-bacitracin-methylene-disalicylate)
---
*AI Analytics · CC0 1.0*